MedPath

Burden of Influenza at Emergency Department (ED) Level in European Countries

Conditions
Influenza, Human
Registration Number
NCT04244500
Lead Sponsor
University of Rostock
Brief Summary

This study plans to conduct enhanced influenza surveillance at a hospital emergency department level independent of underlying influenza-like symptoms.

Detailed Description

Study objectives

Primary:

- Measure the proportion of non-traumatic emergency department (ED) visits infected with influenza during the peak of the influenza season

Secondary:

* Describe the demographic and medical profile of influenza-related and non-influenza-related visits

* Identify socio-demographic or other risk factors associated with ED visit outcome

* Describe the influenza positivity rate among ED visits for different causes

* Measure the proportion of influenza positive patients without classical ILI symptoms

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
2500
Inclusion Criteria
  • All adult patients seeking care at participating ED during the influenza season
  • Participants and/or guardian providing informed consent and/or assent, as appropriate, to participate.
Exclusion Criteria
  • Individuals reporting having suffered a traumatic injury without other conditions.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
influenza status at admission to ED (positive vs. negative)at admission to ED

proportion of non-traumatic emergency department (ED) visits infected with influenza during the peak of the influenza season

Secondary Outcome Measures
NameTimeMethod
influenza without classical symptoms of influenza-like illnessat admission to ED

Measure the proportion of influenza positive patients without classical ILI symptoms

demographic and medical profileat admission to ED

demographic and medical profile of influenza-related and non-influenza-related visits

socio-demographic or other risk factorsat admission to ED

Identify socio-demographic or other risk factors associated with ED visit outcome

Trial Locations

Locations (1)

University of Rostock

🇩🇪

Rostock, Germany

University of Rostock
🇩🇪Rostock, Germany
Martin Bienengraeber, Dr.
Contact
+49381494 5031
dekanat.forschung@med.uni-rostock.de
Micha Loebermann, PD Dr.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.